Published :
Tables : 55
Figures : 35
Category : Healthcare
No. of Pages : 200
Report Code : HC-1186
Protein Sequencing Market is poised to register a CAGR of 3.3% during the forecast period 2022 to 2028. The increasing focus from pharmaceutical biotechnology companies towards target-based drug development is expanding the market growth. Advancements in analytical techniques and clinical mass spectrometry are also stimulating market growth. Besides, increasing financial support from public and private organizations for proteomics coupled with technological evolution for the identification of isobaric remnants in protein sequences are positively influencing the market as well. The protein sequencing market is bifurcated into product & service, technology, application, end-user, and region. In terms of product & service, protein sequencing services are expected to be the front runner of the market. An increasing number of sequencing procedures alongside technological advancements remains the key factor driving the demand for protein sequencing products. Reagents and consumables are also expected to show notable growth owing to the rise in the number of sequencing procedures and advancements in protein sequencing technology. Based on technology, mass spectrometry is expected to witness high growth owing to its benefits such as identification of modified proteins and cost-efficiency. Prominent players aiming towards the launch of technologically advanced spectrometry instruments are expanding the protein sequencing market size significantly. In terms of application, biotherapeutics is expected to control the market growth owing to rising antibiotic resistance of microbes and increasing demand for targeted drug therapy. Technological advancements alongside the benefits of protein sequencing-based methods for drug development processes are positively influencing the market as well. Academic institutes and research centers segment are expected to control the growth of the market. Academic institutes and research centres receive hefty funding from public and private organizations for proteomic research. They provide various protein sequencing services such as Edman degradation and mass spectrometry. It also overcomes the problem of budget constraints and a lack of infrastructure. Owing to these features there has been a soaring growth of academic institutes and research centres thus propelling the market. Based on the region, North America is the global leader of the market. Increasing expenditure and research of major biotechnology and pharmaceutical companies is driving the market growth in the region. The rising focus towards structure-based drug design alongside an increase in proteomic research is boosting the presence of the market in the region. The development of protein sequencing data analysis solutions is stimulating the growth of the market in the region. Major players of the market are: Agilent Technologies, Inc., Bioinformatics Solutions, Charles River Laboratories, Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters. Market Segmentation: By Product and Service • Sample Preparation Products & Services • Protein Sequencing Products o Reagents & Consumables o Instruments • Mass Spectrometry Instruments • Edman Degradation Sequencers o Analysis Products/Software • Protein Sequencing Services By Technology • Edman Degradation • Mass Spectrometry By Application • Biotherapeutics • Genetic Engineering • Other Applications By End User • Academic Institutes & Research Centers • Pharmaceutical & Biotechnology Companies • Other End Users By Region • North America • Europe • Asia Pacific • Latin America • Rest of the World Competitive Landscape: Thermo Fisher Scientific is one of the biggest players in the market and through product innovation and technological innovation bolstered the market. The company launched mass spectrometry platforms like Orbitrap, Fusion Lumos Tribrid Mass Spectrum. The product launches helped the company's growth in consumables as well Shimadzu in 2018, launched Quadrupole time-of-flight (Q-TOF) LCMS-9030 System SGS S.A acquired Vanguard Sciences Inc in 2018. The acquisition helped SGS S.A to enhance its protein sequencing offering for the safety of food Charles River Laboratories in a bid to support the development and characterization of biosimilars and biologics opened its Biologics Testing Facility Solutions facility in Pennsylvania, US FutureWise Key Takeaways: Growth Prospects SWOT Analysis Key Trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the protein sequencing market by product & service, by technology, by application, by end-user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) Evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and the rest of the world To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The increasing focus from pharmaceutical biotechnology companies towards target-based drug development is expanding the market growth. Advancements in analytical techniques and clinical mass spectrometry are also stimulating market growth. Besides, increasing financial support from public and private organizations for proteomics coupled with technological evolution for the identification of isobaric remnants in protein sequences are positively influencing the market as well. The protein sequencing market is bifurcated into product & service, technology, application, end-user, and region. In terms of product & service, protein sequencing services are expected to be the front runner of the market. An increasing number of sequencing procedures alongside technological advancements remains the key factor driving the demand for protein sequencing products. Reagents and consumables are also expected to show notable growth owing to the rise in the number of sequencing procedures and advancements in protein sequencing technology. Based on technology, mass spectrometry is expected to witness high growth owing to its benefits such as identification of modified proteins and cost-efficiency. Prominent players aiming towards the launch of technologically advanced spectrometry instruments are expanding the protein sequencing market size significantly. In terms of application, biotherapeutics is expected to control the market growth owing to rising antibiotic resistance of microbes and increasing demand for targeted drug therapy. Technological advancements alongside the benefits of protein sequencing-based methods for drug development processes are positively influencing the market as well.
Academic institutes and research centers segment are expected to control the growth of the market. Academic institutes and research centres receive hefty funding from public and private organizations for proteomic research. They provide various protein sequencing services such as Edman degradation and mass spectrometry. It also overcomes the problem of budget constraints and a lack of infrastructure. Owing to these features there has been a soaring growth of academic institutes and research centres thus propelling the market.
Based on the region, North America is the global leader of the market. Increasing expenditure and research of major biotechnology and pharmaceutical companies is driving the market growth in the region. The rising focus towards structure-based drug design alongside an increase in proteomic research is boosting the presence of the market in the region. The development of protein sequencing data analysis solutions is stimulating the growth of the market in the region.
Major players of the market are: Agilent Technologies, Inc., Bioinformatics Solutions, Charles River Laboratories, Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters. Market Segmentation:
By Product and Service • Sample Preparation Products & Services • Protein Sequencing Products o Reagents & Consumables o Instruments • Mass Spectrometry Instruments • Edman Degradation Sequencers o Analysis Products/Software • Protein Sequencing Services
By Technology • Edman Degradation • Mass Spectrometry
By Application • Biotherapeutics • Genetic Engineering • Other Applications
By End User • Academic Institutes & Research Centers • Pharmaceutical & Biotechnology Companies • Other End Users
By Region • North America • Europe • Asia Pacific • Latin America • Rest of the World
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Protein Sequencing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Protein Sequencing Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Protein Sequencing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Protein Sequencing Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million) 7.1 Sample Preparation Products & Services 7.2 Protein Sequencing Products 7.2.1. Reagents & Consumables 7.2.2. Instruments 7.2.2.1. Mass Spectrometry Instruments 7.2.2.2. Edman Degradation Sequencers 7.2.3. Analysis Products/Software 7.3 Protein Sequencing Services 8. Protein Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 8.1 Edman Degradation 8.2 Mass Spectrometry 9. Protein Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1 Biotherapeutics 9.2 Genetic Engineering 9.3 Other Applications 10. Protein Sequencing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Academic Institutes & Research Centers 10.2. Pharmaceutical & Biotechnology Companies 10.3. Other End Users 11. North America Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Agilent Technologies, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Bioinformatics Solutions 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Charles River Laboratories 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Proteome Factory 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Rapid Novor Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Selvita 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. SGS 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Shimadzu Corporation 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Thermo Fisher Scientific Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Waters 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Protein Sequencing Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Protein Sequencing Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Protein Sequencing Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Protein Sequencing Market, By Product and Service Historical Analysis and Forecast 2022-2028 (USD Million) 7.1 Sample Preparation Products & Services 7.2 Protein Sequencing Products 7.2.1. Reagents & Consumables 7.2.2. Instruments 7.2.2.1. Mass Spectrometry Instruments 7.2.2.2. Edman Degradation Sequencers 7.2.3. Analysis Products/Software 7.3 Protein Sequencing Services
8. Protein Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 8.1 Edman Degradation 8.2 Mass Spectrometry
9. Protein Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1 Biotherapeutics 9.2 Genetic Engineering 9.3 Other Applications
10. Protein Sequencing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Academic Institutes & Research Centers 10.2. Pharmaceutical & Biotechnology Companies 10.3. Other End Users
11. North America Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Protein Sequencing Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Agilent Technologies, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Bioinformatics Solutions 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Charles River Laboratories 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Proteome Factory 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Rapid Novor Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Selvita 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. SGS 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Shimadzu Corporation 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Thermo Fisher Scientific Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Waters 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics